- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
EREVAS
EREVAS is listed as a small consultant research supplier in the Scientist.com network, with 1 site in 1 country.
View EREVAS on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
1
Countries
1
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small consultant
Data Science/Bioinformatics
- RWE/HEOR Data Science and Modeling A process that helps make sense of your clinical data
- RWE/HEOR Software Tools Software designed to serve the needs of RWE/HEOR research groups.
Disease Models
- Disease Simulation Modeling Disease Simulation Modeling
HEOR
- Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
- Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
- Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
- Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
- Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
- Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
Market Access
- Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
- Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
Medical Communications
- Animated Content Development of diverse visual, interactive digital assets like infographics, data visualizations, and short animations to explain complex medical and scientific concepts simply.
- Competitive Intelligence Develop a coordinated competitive intelligence program which contains a systematic collection and analysis of information from multiple sources about a specific business's industry.
- Data Visualization Visualize data collected from clinical trials and/or clinical research.
- Distribution Strategy & Channel Recommendations Developing plans for how and where medical content (e.g., publications, training, MOA videos) will be efficiently delivered to the target healthcare audience.
- Medical Q&As Developing pre-approved, standardized documents containing accurate, balanced answers to anticipated scientific inquiries about a product or disease.
- Medical Science Liaison (MSL) External Presentation Develop and design Medical Science Liaison External Presentations.
Show all 10 in Medical Communications
- Medical Science Liaison (MSL) Support Support services for Medical Science Liaisons (MSL).
- Medical Science Liasion (MSL) Training Training for medical science liaisons who want to work in pharmaceutical, biotechnology, medical device, and managed care companies.
- Review Article/ Submission Drafting and managing the process of submitting an objective, comprehensive summary of the current literature on a disease or treatment area to a peer-reviewed journal.
- Sales Training Modules Develop and distribute sales training modules.
Show all 25 services
Medical/Commercial
- Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.
Model Development
- Custom Model Development Develop a custom disease model.
Real World Evidence & Data
- RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
Regulatory Affairs
- Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.
- Website
- erevas.com/digitalpharma
Where it operates
Sites by country, with the cities in each.
-
Luxembourg 1 site
Work with EREVAS on Scientist.com
For prices, more details, or to contact EREVAS, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.